William J. Murphy

24.3k total citations · 3 hit papers
330 papers, 16.8k citations indexed

About

William J. Murphy is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, William J. Murphy has authored 330 papers receiving a total of 16.8k indexed citations (citations by other indexed papers that have themselves been cited), including 229 papers in Immunology, 109 papers in Oncology and 79 papers in Hematology. Recurrent topics in William J. Murphy's work include Immune Cell Function and Interaction (166 papers), T-cell and B-cell Immunology (91 papers) and Immunotherapy and Immune Responses (89 papers). William J. Murphy is often cited by papers focused on Immune Cell Function and Interaction (166 papers), T-cell and B-cell Immunology (91 papers) and Immunotherapy and Immune Responses (89 papers). William J. Murphy collaborates with scholars based in United States, China and Japan. William J. Murphy's co-authors include Bruce R. Blazar, Dan L. Longo, Joost J. Oppenheim, Dennis D. Taub, Miriam R. Anver, Mehrdad Abedi, Rosalba Salcedo, Howard A. Young, Robert J. Canter and Hynda K. Kleinman and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

William J. Murphy

319 papers receiving 16.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression

2000 719 citations William J. Murphy et al. Blood profile →
Advances in graft-versus-host disease biology and therapy

2012 626 citations Bruce R. Blazar, William J. Murphy et al. profile →
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

2011 532 citations Qing Zhou, Meghan E. Munger et al. Blood profile →

Peers

Countries citing papers authored by William J. Murphy

Since Specialization

Citations

This map shows the geographic impact of William J. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. Murphy more than expected).

Fields of papers citing papers by William J. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William J. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. Murphy. The network helps show where William J. Murphy may publish in the future.

Co-authorship network of co-authors of William J. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of William J. Murphy. A scholar is included among the top collaborators of William J. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William J. Murphy. William J. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	What’s in a name? Memory NK cells for cancer immunotherapy 2025 ·Journal for ImmunoTherapy of Cancer ·Sean J. Judge, (unknown), William J. Murphy, Robert J. Canter	0
2	Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma 2024 ·Journal of Surgical Oncology ·(unknown), (unknown), Sean J. Judge, Arta M. Monjazeb, Steven W. Thorpe, William J. Murphy, Jing Lyu, Daiwen Chen, Cyrus Bateni, Robert J. Canter	0
3	Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens? 2024 ·Journal for ImmunoTherapy of Cancer ·Robert J. Canter, Sean J. Judge, (unknown), Daniel Yoon, William J. Murphy	3
4	Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), H. Harris, Sean J. Judge, Marshall Lammers, (unknown), Eric G. Johnson, (unknown), William J. Murphy, C. Titus Brown, Robert B. Rebhun, Michael S. Kent, Robert J. Canter	4
5	PD-1 signaling serves a dual role in suppressing T cell activation but also in protecting from activation-induced cell death 2023 ·The Journal of Immunology ·(unknown), Lam T. Khuat, Catherine T. Le, (unknown), (unknown), Robert J. Canter, Arta M. Monjazeb, William J. Murphy	2
6	Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the “obesity paradox” 2023 ·Frontiers in Immunology ·(unknown), (unknown), Lam T. Khuat, Ziming Wang, (unknown), Ethan G. Aguilar, Kevin Stoffel, Sai Yendamuri, Randall J. Smith, Sarbajit Mukherjee, Joseph Barbi, Robert J. Canter, Arta M. Monjazeb, William J. Murphy	12
7	Asymmetrical Expression of PD1 and CD25 in T-cells Post-Initial Activation 2023 ·The Journal of Immunology ·(unknown), (unknown), (unknown), Daniel Yoon, William J. Murphy	1
8	Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), (unknown), Sean J. Judge, Morgan Darrow, (unknown), (unknown), Nikhil Joshi, Matthew L. Settles, Blythe Durbin‐Johnson, Alicia A. Gingrich, Arta M. Monjazeb, Janai R. Carr, (unknown), William J. Murphy, Jonathan A. Eisen, Robert J. Canter	18
9	Skin-Resident β2AR Signaling Delays Burn Wound Healing 2021 ·Journal of Investigative Dermatology ·Alan V. Nguyen, (unknown), Marilyn Wang, (unknown), Michelle D. Bagood, Cordelia Dunai, (unknown), William J. Murphy, R. Rivkah Isseroff, Athena M. Soulika	2
10	Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway 2019 ·JCI Insight ·Maite Álvarez, Federico Simonetta, Jeanette Baker, Antonio Pierini, (unknown), (unknown), William J. Murphy, Robert S. Negrin	72
11	Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality 2019 ·The Journal of Immunology ·Govindarajan Thangavelu, Yu‐Chi Lee, Michaël Loschi, (unknown), Colby J. Feser, Brent H. Koehn, Elizabeth C. Nowak, Robert Zeiser, Jonathan S. Serody, William J. Murphy, David H. Munn, Pierre Chambon, Randolph J. Noelle, Bruce R. Blazar	11
12	Moving forward to address key unanswered questions on targeting PD-1/PD-L1 in cancer: limitations in preclinical models and the need to incorporate human modifying factors 2019 ·Journal for ImmunoTherapy of Cancer ·Catherine T. Le, William J. Murphy	7
13	Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma 2018 ·Veterinary and Comparative Oncology ·Sita S. Withers, Katherine A. Skorupski, Daniel York, (unknown), Kevin Woolard, Renée Laufer Amorim, Ellen E. Sparger, Carlos O. Rodriguez, Stephen J. McSorley, Arta M. Monjazeb, William J. Murphy, Robert J. Canter, Robert B. Rebhun	37
14	Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies 2016 ·Clinical Cancer Research ·Arta M. Monjazeb, Michael S. Kent, Steven K. Grossenbacher, Christine Mall, Anthony E. Zamora, Annie Mirsoian, Mingyi Chen, Amir Kol, Stephen L. Shiao, (unknown), Julian R. Perks, William T. N. Culp, Ellen E. Sparger, Robert J. Canter, Gail D. Sckisel, William J. Murphy	91
15	Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity 2015 ·Cancer Research ·Anil Shanker, Samuel T. Pellom, (unknown), Menaka C. Thounaojam, (unknown), Alan D. Brooks, Hideo Yagita∥, Daniel W. McVicar, William J. Murphy, Dan L. Longo, Thomas J. Sayers	23
16	GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells 2015 ·Blood ·Brent H. Koehn, Petya Apostolova, Jessica M. Haverkamp, Jeffrey S. Miller, Valarie McCullar, Jakub Tolar, David H. Munn, William J. Murphy, W. June Brickey, Jonathan S. Serody, Dmitry I. Gabrilovich, Vincenzo Bronte, Peter J. Murray, Jenny P.‐Y. Ting, Robert Zeiser, Bruce R. Blazar	91
17	Therapeutic Benefit of Bortezomib on Acute Graft-versus-Host Disease Is Tissue Specific and Is Associated with Interleukin-6 Levels 2014 ·Biology of Blood and Marrow Transplantation ·Chien-Chun Steven Pai, Hui-Hua Hsiao, Kai Sun, Mingyi Chen, Takeshi Hagino, (unknown), Christine Mall, Bruce R. Blazar, Arta M. Monjazeb, Mehrdad Abedi, William J. Murphy	17
18	Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia 2010 ·Blood ·Qing Zhou, Meghan E. Munger, Steven L. Highfill, Jakub Tolar, Brenda J. Weigel, Megan Riddle, Arlene H. Sharpe, Daniel A. Vallera, Miyuki Azuma, Bruce L. Levine, Carl H. June, William J. Murphy, David H. Munn, Bruce R. Blazar	230
19	CD16 cross-linking blocks rearrangement of the TCR beta locus and development of alpha beta T cells and induces development of NK cells from thymic progenitors. 1998 ·PubMed ·Scott K. Durum, Chong Kil Lee, Theresa M. Geiman, William J. Murphy, Kathrin Muegge	9
20	Cancer mortality in Georgia. 1961 ·PubMed ·William J. Murphy	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact